Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (1024)

Name Institution Why
Kenneth Carl Anderson, M.D.Dana-Farber Cancer Institute Why?
Paul Gerard Guy Richardson, M.B.,B.S.Dana-Farber Cancer Institute Why?
Stephen John Haggarty, Ph.D.Massachusetts General Hospital Why?
Ralph Mazitschek, Ph.D.Massachusetts General Hospital Why?
Jacob M Hooker, Ph.D.Massachusetts General Hospital Why?
Jay Hans Kalin, Ph.D.Harvard Medical School Why?
Teru Hideshima, Ph.D., M.D.Dana-Farber Cancer Institute Why?
George Velmahos, M.D.Massachusetts General Hospital Why?
Jacob Laubach, M.D.Dana-Farber Cancer Institute Why?
Benjamin L. Ebert, M.D., D.Phil.Dana-Farber Cancer Institute Why?
Daphne A Haas-Kogan, M.D.Dana-Farber Cancer Institute Why?
Nikhil C Munshi, M.D., M.B.,B.S.Dana-Farber Cancer Institute Why?
E. Antonio Chiocca, M.D.,Ph.D.Brigham and Women's Hospital Why?
Eugene Yoshio Fukudome, M.D.Beth Israel Deaconess Medical Center Why?
Leigh Ellis, Ph.D.Dana-Farber Cancer Institute Why?
Per Page    Page  of 69last Nextnext
Search Criteria
  • Histone Deacetylase Inhibitors
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.